Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05018416
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Who this might be right for
Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus
Prokidney 53
Early research (Phase 1)Study completedNCT01418677
What this trial is testing

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Eisai Inc. 19
Early research (Phase 1)Study completedNCT03596567
What this trial is testing

Glasdegib Renal Impairment Study

Who this might be right for
Renal Impairment
Pfizer 18
Testing effectiveness (Phase 2)Study completedNCT01569828
What this trial is testing

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Who this might be right for
PharmacokineticsRenal ImpairedHealthy Volunteer
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT02813798
What this trial is testing

Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal ImpairmentHealthy
GlycoMimetics Incorporated 28
Early research (Phase 1)Study completedNCT01929109
What this trial is testing

LY2409021 in Participants With Different Levels of Kidney Function

Who this might be right for
Kidney Failure, ChronicRenal Insufficiency, Chronic
Eli Lilly and Company 47
Large-scale testing (Phase 3)Study completedNCT00150566
What this trial is testing

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

Who this might be right for
Kidney Failure, Chronic
Shire 460
Early research (Phase 1)Study completedNCT06598956
What this trial is testing

To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects

Who this might be right for
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 32
Not applicableStudy completedNCT00427037
What this trial is testing

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Who this might be right for
Chronic Kidney DiseaseVitamin D Deficiency
Atlanta VA Medical Center 34
Early research (Phase 1)Study completedNCT04532918
What this trial is testing

Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers

Who this might be right for
Chronic Kidney Disease
AstraZeneca 14
Early research (Phase 1)Looking for participantsNCT07141030
What this trial is testing

Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Obesity/Overweight
Gan & Lee Pharmaceuticals. 32
Testing effectiveness (Phase 2)Study completedNCT01424319
What this trial is testing

Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 58
Large-scale testing (Phase 3)Study completedNCT00111098
What this trial is testing

Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

Who this might be right for
Kidney Disease
Amgen 150
Large-scale testing (Phase 3)Study completedNCT00520806
What this trial is testing

Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure

Who this might be right for
Heart Failure, Congestive
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 1,161
Large-scale testing (Phase 3)Study completedNCT01651000
What this trial is testing

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO IP Holdings II, Inc. 213
Large-scale testing (Phase 3)Study completedNCT03183245
What this trial is testing

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Who this might be right for
Renal FailureEnd Stage Renal DiseaseHemodialysis+1 more
Humacyte, Inc. 242
Not applicableLooking for participantsNCT07438002
What this trial is testing

Analysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment

Who this might be right for
Chronic Kidney Disease
Casa di Cura Dott. Pederzoli 50
Not applicableStudy completedNCT03157960
What this trial is testing

Effect of Acute Fructose Load in Human

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2
Karolinska University Hospital 20
Not applicableWithdrawnNCT05352425
What this trial is testing

Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension

Who this might be right for
Uncontrolled Hypertension
Vascular Dynamics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03574363
What this trial is testing

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHypertension
KBP Biosciences 162
Next Page